Suppr超能文献

五元杂芳族衍生物作为钾离子竞争性酸阻滞剂(P-CABs)的合成研究

Synthetic studies of five-membered heteroaromatic derivatives as potassium-competitive acid blockers (P-CABs).

作者信息

Arikawa Yasuyoshi, Hasuoka Atsushi, Nishida Haruyuki, Hirase Keizo, Inatomi Nobuhiro, Takagi Terufumi, Tarui Naoki, Kawamoto Makiko, Imanishi Akio, Itoh Fumio, Kajino Masahiro

机构信息

Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, 26-1, Muraokahigashi-2-chome, Fujisawa, Kanagawa 251-8555, Japan.

Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, 26-1, Muraokahigashi-2-chome, Fujisawa, Kanagawa 251-8555, Japan.

出版信息

Bioorg Med Chem Lett. 2015;25(10):2037-40. doi: 10.1016/j.bmcl.2015.03.094. Epub 2015 Apr 6.

Abstract

On the basis of a series of novel and potent potassium-competitive acid blockers represented by 1-sulfonylpyrrole derivative 7, we prepared several five-membered heterocyclic analogues (8) and evaluated their H(+),K(+)-ATPase activities in vitro. We also assessed the role of the methylaminomethyl side chain by comparison with methylamino and ethylamino derivatives. We observed that the five-membered core ring and its orientation affect inhibitory activity and that the methylaminomethyl moiety is the best side chain. On the basis of potency and ligand-lipophilicity efficiency, compound 7 remains the most drug-like of the compounds studied to date. This study revealed the factors necessary for potent H(+),K(+)-ATPase inhibition, such as differences in electron density, the properties of the lone pair at each apical position of the heteroaromatic ring, and the geometry of the substituents.

摘要

基于以1-磺酰基吡咯衍生物7为代表的一系列新型强效钾竞争性酸阻滞剂,我们制备了几种五元杂环类似物(8),并在体外评估了它们的H⁺,K⁺-ATP酶活性。我们还通过与甲氨基和乙氨基衍生物比较,评估了甲基氨基甲基侧链的作用。我们观察到五元核心环及其取向影响抑制活性,并且甲基氨基甲基部分是最佳侧链。基于效力和配体-亲脂性效率,化合物7仍然是迄今为止所研究化合物中最具药物样性的。这项研究揭示了强效抑制H⁺,K⁺-ATP酶所需的因素,例如电子密度的差异、杂芳环每个顶端位置孤对电子的性质以及取代基的几何形状。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验